LSTM Home > LSTM Research > LSTM Online Archive

Low rate of bacterial co-infection in patients with COVID-19

Adler, Hugh ORCID:, Ball, Robert, Fisher, Michael, Mortimer, Kalani and Vardhan, Madhur S (2020) 'Low rate of bacterial co-infection in patients with COVID-19'. lancet microbe, Vol 1, Issue 2, E62.

[img] Text
Bacterial co-infection in COVID-19 patients.docx - Accepted Version
Restricted to Repository staff only

Download (25kB)
HA L.Microbe.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (41kB) | Preview


We agree with Michael J Cox and colleagues1 that clinical management of COVID-19 would be enhanced by further characterisation of bacterial co-infections. A few case reports have described examples of such co-infections.2, 3, 4 However, national5 and international6 guidelines recommend empirical antibiotics for all patients who are severely ill with suspected COVID-19, and that cessation of therapy is left to the clinicians' discretion. Pending the widespread availability of metagenomic sequencing as envisaged by Cox and colleagues,1 we argue that traditional diagnostics still have a role.

Item Type: Article
Subjects: WA Public Health > WA 105 Epidemiology
WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases
WC Communicable Diseases > Infection. Bacterial Infections > General Infection > WC 195 Infection. Cross infection. Laboratory infection
WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 505 Viral respiratory tract infections
WX Hospitals and Other Health Facilities > WX 100 General works
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):
Depositing User: Stacy Murtagh
Date Deposited: 11 Jun 2020 15:16
Last Modified: 25 Aug 2020 09:43


View details

Actions (login required)

Edit Item Edit Item